My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Avanzanite Bioscience B.V.
Avanzanite Expands Italian Operations with General Manager Appointment
Today 1:30 EDT
From
Avanzanite Bioscience B.V.
Via
Business Wire
Avanzanite Bioscience Welcomes Dr. Mark Bechter as SVP Medical Affairs
September 10, 2025
From
Avanzanite Bioscience B.V.
Via
Business Wire
Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND® in Rare Blood Disorders
June 09, 2025
From
Avanzanite Bioscience B.V.
Via
Business Wire
Avanzanite Bioscience Appoints Sotiris Botozis as General Manager Southern Europe
April 10, 2025
From
Avanzanite Bioscience B.V.
Via
Business Wire
Avanzanite Bioscience Appoints Chief Financial Officer
February 03, 2025
From
Avanzanite Bioscience B.V.
Via
Business Wire
Avanzanite Bioscience Announces Appointment of Chief Technical Officer to Accelerate European Expansion and Drive Growth
January 13, 2025
From
Avanzanite Bioscience B.V.
Via
Business Wire
Avanzanite Bioscience Reports European Commission's Authorisation of Orphan Medicinal Product AKANTIOR®
August 27, 2024
From
Avanzanite Bioscience B.V.
Via
Business Wire
Avanzanite Bioscience Reports AKANTIOR® Received Positive CHMP Opinion and Announces Corporate Expansion Into 26 European Countries
June 03, 2024
From
Avanzanite Bioscience B.V.
Via
Business Wire
Avanzanite Bioscience Further Strengthens Leadership Team With Country Manager of Germany
September 19, 2023
From
Avanzanite Bioscience B.V.
Via
Business Wire
Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal® For the Treatment of Rare Kidney Disease in Germany, Austria, Switzerland and Greece
February 28, 2023
From
Avanzanite Bioscience B.V.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.